0.0650CAD+8.33%Mkt Cap: 45.61M CADP/E: —Last update: 2026-05-26
MedMira Inc., a biotechnology company, researches, develops, manufactures, and sells rapid diagnostics and technology platforms in North America, Europe, and internationally. The company offers Reveal HIV, a test that de…
Industry Peers
Biotechnology110.61BUSDP/E 25.8
106.49BDKKP/E 20.5
66.47BUSDP/E 15.5
46.51BEURP/E 30.5
43.17BEURP/E 35.9
39.41BUSDP/E 74.0
32.84BUSD—
31.18BSEKP/E 46.1
Indicators:|
Key Statistics
Company
Market Cap45.61M CAD
Enterprise Value59.40M CAD
Revenue (TTM)188.50K CAD
Gross Profit172.85K CAD
Net Income (TTM)-4.52M CAD
Revenue/Share0.0000 CAD
Last Price0.0650 CAD
Fiscal Year EndJul 2025
MR QuarterJan 2026
Employees—
CountryCA
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-24.75
EV/Revenue315.11
P/S223.37
P/B-1.76
EPS (TTM)0.00
EPS (Forward)—
52W Range
0.050025% of range0.1100
52W High0.1100 CAD
52W Low0.0500 CAD
Profitability
Gross Margin71.87%
Oper. Margin-1653.06%
EBITDA Margin0.00%
Profit Margin-1881.18%
ROE20.05%
ROA-122.89%
Growth
Revenue Growth-64.50%
Earnings Growth—
Cash Flow & Leverage
Operating CF-3.15M CAD
CapEx (TTM)7.47K CAD
FCF Margin-362.88%
FCF Yield-1.50%
Net Debt17.29M CAD
Net Debt/EBITDA-7.20
Balance Sheet
Debt/Equity-0.47
Current Ratio0.07
Quick Ratio0.06
Book Value/Sh-0.0340 CAD
Cash/Share0.0000 CAD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 CAD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.701.73M
Float209.72M
Insiders65.54%
Institutions0.00%
Short Interest
Short Ratio0.0d
Short % Out.0.00%
Shares Short1.05K
Short (prev mo.)28.68K
Technical
SMA 500.0634 (+2.5%)
SMA 2000.0741 (-12.3%)
Beta0.75
S&P 52W Chg28.31%
Avg Vol (30d)70.69K
Avg Vol (10d)51.02K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—